MedTrace Logo

Laparoscopic-guided TAP Block in Patients Undergoing Gastric Bypass

NCT03203070 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2017-06-29

No results posted yet for this study

Summary

A prospective randomized trial will be performed. Patients undergoing gastric bypass will be randomized into 2 groups: patients undergoing laparoscopic-guided transversus abdominis plane (TAP) block as part of multimodal analgesia (Group 1), associated with postoperative intravenous analgesia, and patients receiving only postoperative intravenous analgesia (Group 2).

Postoperative pain will be assessed with a Visual Analogic Scale 24h after surgery and morphine needs will be quantified.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Metamizol iv

Postoperative analgesia iv with Metamizol 2g/8h will be administered.

PROCEDURE

TAP block

Intraoperative laparoscopic-guided TAP block will be performed with 30ml Bupivacaine 0.5%

Sponsors & Collaborators

  • Hospital General Universitario Elche

    lead OTHER

Principal Investigators

  • Manule Duran · Hospital Universitario Rey Juan Carlos

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03203070 on ClinicalTrials.gov